KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test
At DNA Labs UAE, we offer the KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test. This test is designed to diagnose and identify mutations or variations in the KIF23 gene, which is associated with a rare genetic disorder called dyserythropoietic anemia, congenital, type 3.
Test Details
The KIF23 gene is responsible for the production of red blood cells. When mutations or variations occur in this gene, it can lead to dyserythropoietic anemia, congenital, type 3, a condition characterized by a reduced production of red blood cells, resulting in anemia.
Our KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes or even the entire genome. This advanced genetic testing method involves sequencing the DNA of an individual to detect any changes in the genetic code.
By comparing the individual’s DNA sequence to a reference sequence, our test can identify variations or mutations in the KIF23 gene that may be responsible for dyserythropoietic anemia, congenital, type 3. This information is crucial for accurate diagnosis, genetic counseling, and potentially the development of targeted treatments or interventions.
Test Components and Price
Our KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test is priced at 4400.0 AED. The test can be performed using either blood or extracted DNA as the sample condition. Alternatively, one drop of blood can be collected on an FTA Card for testing.
Report Delivery and Method
Once the sample is received, the report for the KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test will be delivered within 3 to 4 weeks. The test utilizes NGS technology for accurate and comprehensive analysis.
Test Type and Doctor
The KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test falls under the category of Hematology tests. It is recommended to consult with a Hematologist for this specific test.
Test Department and Pre-Test Information
Our Genetics department is responsible for conducting the KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test. Prior to the test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by dyserythropoietic anemia, congenital, type 3.
Genetic counseling is essential for understanding the inheritance pattern of the disorder and identifying potential carriers within the family. This information aids in the interpretation of test results and provides guidance and support for the patient and their family.
At DNA Labs UAE, we strive to provide accurate and reliable genetic testing services. Our KIF23 Gene Dyserythropoietic Anemia Congenital Type 3 Genetic Test is performed by healthcare professionals and genetic specialists who are experienced in interpreting the results and providing appropriate guidance and support.
Test Name | KIF23 Gene Dyserythropoietic anemia congenital type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hematology |
Doctor | Hematologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KIF23 Gene Dyserythropoietic anemia, congenital, type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIF23 Gene Dyserythropoietic anemia, congenital, type 3 NGS Genetic DNA Test gene KIF23 |
Test Details |
The KIF23 gene is associated with a rare genetic disorder called dyserythropoietic anemia, congenital, type 3. This disorder affects the production of red blood cells, leading to anemia. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of dyserythropoietic anemia, congenital, type 3, NGS genetic testing can be used to identify mutations or variations in the KIF23 gene that may be responsible for the disorder. NGS genetic testing involves sequencing the DNA of an individual to detect any changes in the genetic code. By comparing the individual’s DNA sequence to a reference sequence, variations or mutations in the KIF23 gene can be identified. This information can then be used for diagnostic purposes, genetic counseling, and potentially for the development of targeted treatments or interventions. It is important to note that NGS genetic testing is typically performed by healthcare professionals or genetic specialists who can interpret the results and provide appropriate guidance and support. |